T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.37% |
| 2 | Financials | 13.66% |
| 3 | Consumer Discretionary | 13.64% |
| 4 | Technology | 10.86% |
| 5 | Industrials | 10.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCH
801
DELISTED
PotlatchDeltic
PCH
| $54.9M | 0.01% |
1,555,250
+19,200
| +1% | +$708K |
|
802
Cheesecake Factory
CAKE
$5.57B
| $54.9M | 0.01% |
1,006,380
-20,700
| -2% | -$1.07M |
|
803
Teradyne
TER
$62.9B
| $54.7M | 0.01% |
2,834,278
-105,444
| -4% | -$2.11M |
|
|
IMPV
804
DELISTED
Imperva, Inc.
IMPV
| $54.3M | 0.01% |
802,235
-304,545
| -28% | -$16.8M |
|
|
CIR
805
DELISTED
CIRCOR International, Inc
CIR
| $54.3M | 0.01% |
995,000
-7,900
| -0.8% | -$436K |
|
806
Moody's
MCO
$83.8B
| $54.2M | 0.01% |
502,021
-89,810
| -15% | -$9.67M |
|
807
RLI Corp
RLI
$5.86B
| $54M | 0.01% |
2,101,880
-7,800
| -0.4% | -$197K |
|
|
FPO
808
DELISTED
First Potomac Realty Trust
FPO
| $53.9M | 0.01% |
5,235,823
-21,624
| -0.4% | -$233K |
|
809
AGCO
AGCO
$7.06B
| $53.8M | 0.01% |
947,810
+916,260
| +2,904% | +$46.5M |
|
|
TUMI
810
DELISTED
TUMI HLDGS INC COM
TUMI
| $53.7M | 0.01% |
2,618,010
+4,323
| +0.2% | +$94.4K |
|
811
Aflac
AFL
$61B
| $53.6M | 0.01% |
1,722,606
+19,780
| +1% | +$626K |
|
|
HI
812
DELISTED
Hillenbrand
HI
| $53.5M | 0.01% |
1,741,380
+39,950
| +2% | +$1.23M |
|
|
EXPR
813
DELISTED
Express, Inc.
EXPR
| $53.3M | 0.01% |
147,146
-4,376
| -3% | -$1.53M |
|
|
TLMR
814
DELISTED
TALMER BANCORP INC (MI)
TLMR
| $53.1M | 0.01% |
3,168,170
-55,400
| -2% | -$895K |
|
815
TriNet
TNET
$3.14B
| $52.9M | 0.01% |
2,085,200
-2,344,042
| -53% | -$73.3M |
|
816
UFP Industries
UFPI
$4.97B
| $52.7M | 0.01% |
3,037,710
-171,600
| -5% | -$3.14M |
|
817
American Eagle Outfitters
AEO
$2.72B
| $52.7M | 0.01% |
3,058,900
-1,394,790
| -31% | -$23.5M |
|
|
CBL
818
DELISTED
CBL& Associates Properties, Inc.
CBL
| $52.6M | 0.01% |
3,249,900
-4,360,583
| -57% | -$78.6M |
|
819
National Healthcare
NHC
$3.48B
| $52.5M | 0.01% |
807,177
-7,520
| -0.9% | -$477K |
|
|
ARRY
820
DELISTED
Array Biopharma Inc
ARRY
| $52.5M | 0.01% |
7,275,200
-332,900
| -4% | -$2.46M |
|
821
Brown-Forman Class B
BF.B
$13B
| $52.4M | 0.01% |
1,635,234
+38,750
| +2% | +$1.18M |
|
|
STJ
822
DELISTED
St Jude Medical
STJ
| $52.4M | 0.01% |
716,918
-2,610
| -0.4% | -$189K |
|
823
Banco Santander Chile
BSAC
$16.2B
| $51.9M | 0.01% |
2,560,760
-286,282
| -10% | -$6.13M |
|
|
GTLS
824
DELISTED
Chart Industries
GTLS
| $51.8M | 0.01% |
1,449,940
+300
| +0% | +$11K |
|
825
Devon Energy
DVN
$50.1B
| $51.6M | 0.01% |
868,204
+195,240
| +29% | +$12.6M |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.